Sphingomyelin-enriched microdomains define the efficiency of native Ca(2+)-triggered membrane fusion.
Membrane microdomains or ;rafts' are suggested to act as regulators of the exocytotic process and also appear to be the sites of Ca(2+)-triggered membrane fusion. Microdomains are postulated to maintain the localization of ;efficiency' factors, including Ca(2+) sensors and other protein and lipid components. Separation of the fundamental ability to fuse from the efficiency of the process has suggested dependence of efficiency factors on microdomain organization. Cholesterol, a key component of membrane microdomains, contributes to both the efficiency and the fundamental ability to fuse. However, testing for a selective effect of native microdomains on the efficiency of fusion, without affecting membrane cholesterol density, has not been assessed. Hydrolysis of sphingomyelin disrupts native raft domains on secretory vesicles. Disruption of microdomains enriched in sphingomyelin-cholesterol by treatment with sphingomyelinase selectively and dose dependently inhibited the Ca(2+) sensitivity and late kinetics of secretory vesicle fusion. As a native microdomain constituent, sphingomyelin is associated with Ca(2+) sensing through its interaction with other raft-bound lipid and/or protein factors, thereby supporting the physiological Ca(2+) sensitivity of membrane fusion. Furthermore, the sphingomyelinase-driven generation of ceramide, contributing to the total membrane negative curvature, preserves the ability to fuse despite extensive cholesterol removal. Membrane microdomain integrity thus underlies the efficiency of fusion but not the fundamental ability of native vesicles to undergo Ca(2+)-triggered membrane merger. The results are consistent with a fundamental fusion machine of intrinsically low Ca(2+) sensitivity that, supported by accessory ;efficiency' components, facilitates Ca(2+)-triggered bilayer merger under physiological conditions.
Rogasevskaia
Tatiana
T
Departments of Physiology and Biophysics, Biochemistry and Molecular Biology, and Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Faculty of Medicine, Calgary, AB, T2N 4N1, Canada.
Coorssen
Jens R
JR
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002784:Cholesterol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004526:Efficiency; D008561:Membrane Fusion / Q000187:drug effects*; D021962:Membrane Microdomains / Q000502:physiology*; D010063:Ovum; D022142:Secretory Vesicles / Q000187:drug effects / Q000378:metabolism; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D013109:Sphingomyelins / Q000502:physiology*; D047270:Strongylocentrotus purpuratus / Q000502:physiology
D013109:Sphingomyelins; D002784:Cholesterol; D013108:Sphingomyelin Phosphodiesterase; D002118:Calcium